PURE Bioscience, Inc. (PURE)
Company Description
PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally.
The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces.
The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds.
PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.
Country | Canada |
Founded | 1992 |
IPO Date | Aug 8, 1996 |
Industry | Household & Personal Products |
Sector | Consumer Staples |
Employees | 11 |
CEO | Robert F. Bartlett |
Contact Details
Address: 771 Jamacha Road #512 El Cajon, California 92019 United States | |
Phone | 619-596-8600 |
Website | purebio.com |
Stock Details
Ticker Symbol | PURE |
Exchange | OTCMKTS |
Fiscal Year | August - July |
Reporting Currency | USD |
CIK Code | 0001006028 |
CUSIP Number | 74621T209 |
ISIN Number | US74621T2096 |
Employer ID | 33-0530289 |
SIC Code | 2890 |
Key Executives
Name | Position |
---|---|
Robert F. Bartlett | President, Chief Executive Officer and Director |
Mark Stuart Elliott | Vice President of Finance and Principal Financial and Accounting Officer |
Thomas Richard Myers | Executive Vice President of Technology and Development and Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2024 | 8-K | Current Report |
Mar 18, 2024 | 10-Q | Quarterly Report |
Mar 18, 2024 | 8-K | Current Report |
Feb 26, 2024 | 8-K | Current Report |
Jan 10, 2024 | DEF 14A | Other definitive proxy statements |
Dec 19, 2023 | PRE 14A | Other preliminary proxy statements |
Dec 14, 2023 | 10-Q | Quarterly Report |
Dec 14, 2023 | 8-K | Current Report |
Oct 30, 2023 | 10-K | Annual Report |
Oct 30, 2023 | 8-K | Current Report |